share_log
Reuters ·  Apr 29 08:00
BioVie Awarded up to $13.1 Million in Funding From U.S. Department of Defense to Evaluate Bezisterim (Ne3107) for the Treatment of Long Covid
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment